| Title: |
PICKING THE BEST NOVEL ORAL ANTICOAGULANT FOR ATRIAL FIBRILLATION: EVIDENCE FROM A WARFARIN-CONTROLLED NETWORK META-ANALYSIS |
| Authors: |
Roversi, S; MALAVASI, VINCENZO; D'Ascenzo, F; Abbate, A; Castagno, D; Van Tassell, B; CASALI, EDOARDO; Modena, MG |
| Contributors: |
Roversi, S; Malavasi, Vincenzo; D'Ascenzo, F; Abbate, A; Castagno, D; Van Tassell, B; Casali, Edoardo; Modena, Mg |
| Publisher Information: |
ELSEVIER SCIENCE INC; 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA |
| Publication Year: |
2012 |
| Collection: |
Archivio della ricerca dell'Università di Modena e Reggio Emilia (Unimore: IRIS) |
| Description: |
Warfarin is a mainstay atrial ibrillation (AF) treatment, yet it has a narrow therapeutic window. Novel agents have been successfully tested against warfarin, yet no direct comparison among them is available. We thus performed a pair-wise and warfarin-adjusted network metaanalyses of novel oral anticoagulants for AF. |
| Document Type: |
conference object |
| Language: |
English |
| Relation: |
info:eu-repo/semantics/altIdentifier/wos/WOS:000302326700599; ispartofbook:JACC; Congress of American College of Cardiology; volume:59; issue:13; firstpage:E598; lastpage:E598; journal:JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY; https://hdl.handle.net/11380/1148611 |
| DOI: |
10.1016/s0735-1097(12)60599-3 |
| Availability: |
https://hdl.handle.net/11380/1148611; https://doi.org/10.1016/s0735-1097(12)60599-3 |
| Rights: |
info:eu-repo/semantics/closedAccess |
| Accession Number: |
edsbas.C6C3F7 |
| Database: |
BASE |